Signaling Pathway
Namilumab (AMG203) is a human IgG1 monoclonal antibody designed to bind with high affinity to granulocyte-macrophage colony-stimulating factor (GM-CSF), effectively neutralizing its activity. This antibody is primarily utilized in research focused on understanding and treating rheumatoid arthritis, providing a valuable tool for investigating the role of GM-CSF in inflammatory processes.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Namilumab (AMG203) is a human IgG1 monoclonal antibody designed to bind with high affinity to granulocyte-macrophage colony-stimulating factor (GM-CSF), effectively neutralizing its activity. This antibody is primarily utilized in research focused on understanding and treating rheumatoid arthritis, providing a valuable tool for investigating the role of GM-CSF in inflammatory processes. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
